P-5091
-
P-5091
structure -
-
CAS No:
882257-11-6
-
Formula:
C12H7Cl2NO3S2
-
Chemical Name:
P-5091
-
Synonyms:
1-[5-(2,3-dichlorophenyl)sulfanyl-4-nitro-2-thienyl]ethanone;P5091, >=98%;1-[5-(2,3-Dichloro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone;P 005091;P 5091;P005091;P-005091;P5091
- Categories:
-
CAS No:
Characteristics
116
5.1
light yellow to dark yellow
1.60±0.1 g/cm3(Predicted)
DMSO: soluble 10mg/mL, clear
2-8°C
Safety Information
Ⅲ
UN 2811 6.1 / PGIII
3
25
45
T
P264, P270, P273, P301+P310, P321, P330, P405, P501
H301
P-5091 Use and Manufacturing
P005091 is a selective dual inhibitor of the cancer-related deubiquitylating proteases USP7 and USP47.
Computed Properties
Molecular Weight:348.2
XLogP3:5.1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:3
Exact Mass:346.9244408
Monoisotopic Mass:346.9244408
Topological Polar Surface Area:116
Heavy Atom Count:20
Complexity:393
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of P-5091
-
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Latest News on P-5091
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4